In the present study, 5-aza treatment not only exerted antidepressant-like effects and reduced DNA methylation but also significantly increased CRMP2 protein expression in the hippocampal CA1 region, further supporting the notion that DNA methylation-dependent CRMP2 gene expression is involved in the pathogenesis of depression. This evidence concerns the gene DPYSL2 and major depressive disorder.